TCRT · Alaunos Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Boyle Kevin S. Sr. Chief Executive Officer | ▼ Sell | Open Market | 798,236 Shares held | 9/1/2023 | View profile |
| De Groot Eleanor EVP, Operations | ▼ Sell | Open Market | 237,106 Shares held | 12/22/2021 | View profile |
| James Huang Director | ▲ Buy | Grant | 188,333 Shares held | 6/22/2022 | View profile |
| Hagen Heidi Director | ▲ Buy | Open Market | 145,889 Shares held | 9/2/2021 | View profile |
| Robert W. Postma Director | ▲ Buy | Grant | 58,609 Shares held | 7/23/2026 | View profile |
| Jaime Vieser Director | ▲ Buy | Grant | 47,642 Shares held | 7/23/2026 | View profile |
| Thistle Mary Director | ▲ Buy | Grant | 45,000 Shares held | 6/22/2022 | View profile |
| Bowden Christopher Director | ▲ Buy | Grant | 44,167 Shares held | 6/22/2022 | View profile |
| Holger Weis Director | ▲ Buy | Grant | 25,483 Shares held | 8/6/2026 | View profile |
| Michael Allen Jerman | ▲ Buy | Grant | 23,759 Shares held | 7/23/2026 | View profile |
| Ferdinand Groenewald Vice President of Finance | ▲ Buy | Grant | 10,775 Shares held | 8/18/2025 | View profile |
Transaction History
| Holger Weis | ▲ Buy | Grant | 4,363 | $9K | 8/6/2026 |
| Robert W. Postma | ▲ Buy | Grant | 8,463 | $16K | 7/23/2026 |
| Jaime Vieser | ▲ Buy | Grant | 8,789 | $17K | 7/23/2026 |
| Michael Allen Jerman | ▲ Buy | Grant | 8,138 | $16K | 7/23/2026 |
| Holger Weis | ▲ Buy | Grant | 4,568 | $9K | 7/23/2026 |
| Holger Weis | ▲ Buy | Grant | 3,880 | $9K | 6/30/2026 |
| Holger Weis | ▲ Buy | Grant | 7,761 | $18K | 6/12/2026 |
| Holger Weis | ▲ Buy | Grant | 3,700 | $9K | 5/22/2026 |
| Jaime Vieser | ▲ Buy | Grant | 6,515 | $17K | 4/29/2026 |
| Robert W. Postma | ▲ Buy | Grant | 6,274 | $16K | 4/29/2026 |
| Michael Allen Jerman | ▲ Buy | Grant | 6,032 | $16K | 4/29/2026 |
| Michael Allen Jerman | ▲ Buy | Grant | 5,406 | $16K | 1/12/2026 |
| Robert W. Postma | ▲ Buy | Grant | 5,622 | $16K | 1/12/2026 |
| Jaime Vieser | ▲ Buy | Grant | 5,839 | $17K | 1/12/2026 |
| Jaime Vieser | ▲ Buy | Grant | 5,340 | $17K | 11/21/2025 |
| Robert W. Postma | ▲ Buy | Grant | 5,142 | $16K | 11/21/2025 |
| Michael Allen Jerman | ▲ Buy | Grant | 4,183 | $13K | 11/21/2025 |
| Ferdinand Groenewald | ▲ Buy | Grant | 10,775 | $0 | 8/18/2025 |
| Robert W. Postma | ▲ Buy | Grant | 4,050 | $0 | 7/3/2025 |
| Jaime Vieser | ▲ Buy | Grant | 3,400 | $0 | 7/3/2025 |
| Robert W. Postma | ▲ Buy | Grant | 20,804 | $61K | 4/13/2025 |
| Jaime Vieser | ▲ Buy | Grant | 17,465 | $0 | 4/13/2025 |
| Robert W. Postma | ▲ Buy | Grant | 20,804 | $61K | 4/13/2025 |
| Jaime Vieser | ▼ Sell | Open Market | 2,182 | $4K | 12/31/2024 |
| Jaime Vieser | ▼ Sell | Open Market | 818 | $2K | 12/31/2024 |
| Boyle Kevin S. Sr. | ▼ Sell | Open Market | 68,014 | $10K | 9/1/2023 |
| Robert W. Postma | ▲ Buy | Open Market | 750,000 | $488K | 11/29/2022 |
| Jaime Vieser | ▲ Buy | Open Market | 1,250,000 | $813K | 11/29/2022 |
| Boyle Kevin S. Sr. | ▼ Sell | Tax Withholding | 18,750 | $45K | 8/30/2022 |
| James Huang | ▲ Buy | Grant | 80,000 | $0 | 6/22/2022 |
| James Huang | ▲ Buy | Grant | 80,000 | $0 | 6/22/2022 |
| Robert W. Postma | ▲ Buy | Grant | 40,000 | $0 | 6/22/2022 |
| Thistle Mary | ▲ Buy | Grant | 40,000 | $0 | 6/22/2022 |
| Thistle Mary | ▲ Buy | Grant | 40,000 | $0 | 6/22/2022 |
| Jaime Vieser | ▲ Buy | Grant | 40,000 | $0 | 6/22/2022 |
| Bowden Christopher | ▲ Buy | Grant | 40,000 | $0 | 6/22/2022 |
| Holger Weis | ▲ Buy | Grant | 40,000 | $0 | 6/22/2022 |
| Robert W. Postma | ▲ Buy | Grant | 40,000 | $0 | 6/22/2022 |
| De Groot Eleanor | ▼ Sell | Open Market | 20,132 | $26K | 12/22/2021 |
| Boyle Kevin S. Sr. | ▲ Buy | Open Market | 9,116 | $13K | 11/17/2021 |
| Boyle Kevin S. Sr. | ▲ Buy | Open Market | 884 | $1K | 11/16/2021 |
| Jaime Vieser | ▲ Buy | Open Market | 100,000 | $191K | 9/29/2021 |
| Robert W. Postma | ▲ Buy | Open Market | 54,492 | $94K | 9/2/2021 |
| Hagen Heidi | ▲ Buy | Open Market | 23,770 | $42K | 9/2/2021 |
| Robert W. Postma | ▲ Buy | Open Market | 20,508 | $35K | 9/2/2021 |
| Holger Weis | ▲ Buy | Open Market | 50,000 | $92K | 9/1/2021 |
| James Huang | ▲ Buy | Open Market | 100,000 | $171K | 9/1/2021 |
| Boyle Kevin S. Sr. | ▲ Buy | Grant | 875,000 | $0 | 8/30/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Alaunos Therapeutics (TCRT) Moves in After-Hours Trading
Alaunos Therapeutics was listed among healthcare stocks moving in Friday's after-market session. The stock is currently trading near its support level of $1.97, with an RSI of 30.4 indicating it is in oversold territory. This price action occurs within a 52-week range of $0.97 to $4.59.
Alaunos Therapeutics (TCRT) Moves in After-Hours Trading. Alaunos Therapeutics was listed among healthcare stocks moving in Friday's after-market session. The stock is currently trading near its support level of $1.97, with an RSI of 30.4 indicating it is in oversold territory. This price action occurs within a 52-week range of $0.97 to $4.59.